Scrip
Synosia reports early clinical data for Parkinson's candidate
04 February 2010
Katie McQue
Please Login to read the full article.
04 February 2010
Katie McQue
Synosia Therapeutics has reported some potentially positive interim results from a Phase IIa study investigating its experimental adenosine 2a (A2a) receptor antagonist SYN-115 as an adjunctive therapy to levodopa in Parkinson's disease.
"These encouraging results suggest that SYN-115 is...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
SCIENCE
- Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
- Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
